Moreover, survival of patients with G1 (Log-rank = 4.345, P = 0.037), G2 (Log-rank = 5.038, P = 0.025) and G3 (Log-rank = 10.535, P = 0.001) ovarian cancer was significantly lower in patients with tumors exhibiting high versus low HBXIP expression (Fig. 3b–d). Here, LAMTOR5 is linked to ovarian carcinoma.